Triamcinolone Acetonide 주사를 이용한 족관절 외과 점액낭염의 치료
Triamcinolone Acetonide Injections for Lateral Malleolar Bursitis of the Ankle
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: This study examined the clinical outcomes and usefulness of triamcinolone acetonide (TA) injections as an option in the conservative treatment of patients with lateral malleolar bursitis of the ankle. Materials and Methods: A total of 27 patients (27 ankles), in whom TA injection had been performed between March 2016 and June 2017, were reviewed retrospectively. After the aspiration of fluid in the lateral malleolar bursal sac, 1 mL (40 mg) of TA was injected into the malleolar bursal sac. After the injection, the ankle was compressed with an elastic cohesive bandage for 2 to 4 weeks. The clinical outcomes and side effects were evaluated at the following time points: 2 weeks, 4 weeks, 3 months, 6 months, and 1 year after TA injection therapy. The responses to treatment were assessed according to the degree of fluctuation, shrinkage of the bursal sac, and soft tissue swelling. Results: The mean age was 62.1 years (range, 41∼81 years); there were 19 males and 8 females. Complete resolution was observed in 26 patients (96.3%) after the first or second application of a TA injection, and a partial response was observed in 1 patient (3.7%) after the first TA injection. The physical component scores of Medical Outcomes Study 36-item Short-Form Health Survey improved from 71.1 to 76.0 at the last follow-up (p=0.001). Associated complications were 1 patient (3.7%) with skin atrophy and 3 patients (11.1%) with transient hyperglycemia in diabetes mellitus. Conclusion: TA injection is a useful and safe procedure for patients not responding to the usual conservative treatment of lateral malleolar bursitis of the ankle.
Abstract
Purpose: This study examined the clinical outcomes and usefulness of triamcinolone acetonide (TA) injections as an option in the conservative treatment of patients with lateral malleolar bursitis of the ankle. Materials and Methods: A total of 27 patients (27 ankles), in whom TA injection had been performed between March 2016 and June 2017, were reviewed retrospectively. After the aspiration of fluid in the lateral malleolar bursal sac, 1 mL (40 mg) of TA was injected into the malleolar bursal sac. After the injection, the ankle was compressed with an elastic cohesive bandage for 2 to 4 weeks. The clinical outcomes and side effects were evaluated at the following time points: 2 weeks, 4 weeks, 3 months, 6 months, and 1 year after TA injection therapy. The responses to treatment were assessed according to the degree of fluctuation, shrinkage of the bursal sac, and soft tissue swelling. Results: The mean age was 62.1 years (range, 41∼81 years); there were 19 males and 8 females. Complete resolution was observed in 26 patients (96.3%) after the first or second application of a TA injection, and a partial response was observed in 1 patient (3.7%) after the first TA injection. The physical component scores of Medical Outcomes Study 36-item Short-Form Health Survey improved from 71.1 to 76.0 at the last follow-up (p=0.001). Associated complications were 1 patient (3.7%) with skin atrophy and 3 patients (11.1%) with transient hyperglycemia in diabetes mellitus. Conclusion: TA injection is a useful and safe procedure for patients not responding to the usual conservative treatment of lateral malleolar bursitis of the ankle.
참고문헌 (17)
- Park KH, "OK-432 sclerotherapy for malleolar bursitis of the ankle", Foot Ankle Int, 34, pp.1389~1394 (2013)
- Choi JH, "Endoscopic versus open bursectomy of lateral malleolar bursitis", Knee Surg Sports Traumatol Arthrosc, 20, pp.1205~1208 (2012)
- Avci S, "Lateral premalleolar bursitis as a result of sitting on the foot", Foot Ankle Int, 22, pp.64~66 (2001)
- Brown TD, "Malleolar bursitis in figure skaters. Indications for operative and nonoperative treatment", Am J Sports Med, 28, pp.109~111 (2000)
- Wittich CM, "Musculoskeletal injection", Mayo Clin Proc, 84, pp.831~836 (2009)
- Carroll MB, "Rilonacept in the treatment of subacromial bursitis : a randomized, non-inferiority, unblinded study versus triamcinolone acetonide", Joint Bone Spine, 82, pp.446~450 (2015)
- Therasse P, "New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada", J Natl Cancer Inst, 92, pp.205~216 (2000)
- Ware JE Jr, "SF-36 health survey update", Spine(Phila Pa 1976), 25, pp.3130~3139 (2000)
- Boutin FJ, "Operative orthopaedics", pp.3419~3432 (1993), J.B. Lippincott
- Hernandez PA, "Clinical aspects of bursae and tendon sheaths of the foot", J Am Podiatr Med Assoc, 81, pp.366~372 (1991)
- Battaglia M, "Efficacy of triamcinolone acetate and methylprednisolone acetonide for intrabursal injection after ultrasound-guided percutaneous treatment in painful shoulder calcific tendonitis : a randomized controlled trial", Acta Radiol, 58, pp.964~970 (2017)
- Kumar A, "Efficacy of methylprednisolone acetate versus triamcinolone acetonide intra-articular knee injection in patients with chronic inflammatory arthritis : a 24-week randomized controlled trial", Clin Ther, 39, pp.150~158 (2017)
- Charalambous CP, "Septic arthritis following intra-articular steroid injection of the knee--a survey of current practice regarding antiseptic technique used during intra-articular steroid injection of the knee", Clin Rheumatol, 22, pp.386~390 (2003)
- Black DM, "Hyperglycemia with non-insulin-dependent diabetes following intraarticular steroid injection", J Fam Pract, 28, pp.462~463 (1989)
- Nichols AW, "Complications associated with the use of corticosteroids in the treatment of athletic injuries", Clin J Sport Med, 15, pp.370~375 (2005)
- Pfenninger JL, "Injections of joints and soft tissue: part II. Guidelines for specific joints", Am Fam Physician, 44, pp.1690~1701 (1991)
- Degreef I, "Complications following resection of the olecranon bursa", Acta Orthop Belg, 72, pp.400~403 (2006)